Their finding shows that the existence of CD4+ T cells is not adequate to propose a tumor in a milieu containing decreased CD8+ T cells and that Foxp3+ T cells might have a negative effect on the potential of CD8+ T cells for fighting against gallbladder cancer. The gene discussed is CD4; the disease is neoplasm.